The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2.88 million Indefinite Delivery Contract (IDC) to Meditrade Medical Trading GMBH, a for-profit limited liability company based in Germany. The IDC, designated SPE2DS23D0001, enables the procurement of a broad range of medical commodities including laboratory reagents, surgical items, diagnostic tests, medical panels, and cartridges to support U.S. military healthcare and testing operations, primarily for personnel stationed in Germany and other European locations. Meditrade GMBH also holds two $2 million Blanket Purchase Agreements (BPAs) with the U.S. Army Medical Command for the supply of additional medical supplies and laboratory items. These contract vehicles allow various defense agencies to efficiently acquire critical medical resources to meet the healthcare needs of the U.S. armed forces worldwide. The IDC and BPAs do not have any set-aside designations, indicating Meditrade GMBH's ability to compete effectively in the open federal market.
The original contract opportunity, solicitation SPE2DS-22-Q-0083, was an unrestricted procurement conducted under simplified acquisition procedures. It sought to establish multiple IDIQ contracts for general-purpose laboratory reagents and controls to support the U.S. Army Medical Center Europe (USAMMCE) in Kaiserslautern, Germany. The applicable NAICS code was 325413 - In Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1,200 employees. The contract aims to provide essential medical supplies and equipment necessary for U.S. military healthcare and pandemic response efforts in Europe.
Generated 2/12/25, 9:07 AM